4//SEC Filing
Stockwell Lynn 4
Accession 0001213900-25-094436
CIK 0002040475other
Filed
Sep 30, 8:00 PM ET
Accepted
Oct 1, 10:40 AM ET
Size
11.9 KB
Accession
0001213900-25-094436
Insider Transaction Report
Form 4
Stockwell Lynn
DirectorCEO and Exe. Chair of Board10% Owner
Transactions
- Sale
Ordinary shares
2025-09-26−7,966,667→ 6,708,333 total(indirect: See Footnote) - Purchase
Ordinary shares
2025-09-26+700,000→ 15,075,000 total(indirect: See Footnote) - Other
Ordinary shares
2025-09-26−400,000→ 14,675,000 total(indirect: See Footnote) - Purchase
Rights to receive ordinary shares
2025-09-26+700,000→ 700,000 total(indirect: See Footnote)→ Ordinary shares (70,000 underlying)
Footnotes (4)
- [F1]Reflects 700,000 private units acquired by Drugs Made In America Acquisition II LLC, the Issuer's sponsor. Each private unit consists of one ordinary share and one right to receive one-tenth (1/10) of an ordinary share upon the consummation of an initial business combination. The private units were purchased at $10 per unit for an aggregate purchase price of $7,000,000. Lynn Stockwell is the managing member of the sponsor and has voting and dispositive power over the securities held of record by the sponsor. Ms. Stockwell disclaims any beneficial ownership of the securities held by the sponsor, except to the extent of her pecuniary interest therein.
- [F2]As of the Transaction Date, the sponsor transferred an aggregate of 400,000 ordinary shares to certain of the Issuer's officers and directors for no consideration.
- [F3]As of the Transaction Date, pursuant to share transfer agreements, the sponsor transferred an aggregate of 7,966,667 ordinary shares to a number of accredited investors for consideration ranging from no consideration to $1.50 per share.
- [F4]The rights convert automatically into ordinary shares at the completion of the Issuer's initial business combination.
Documents
Issuer
Drugs Made In America Acquisition II Corp.
CIK 0002040475
Entity typeother
Related Parties
1- filerCIK 0001927032
Filing Metadata
- Form type
- 4
- Filed
- Sep 30, 8:00 PM ET
- Accepted
- Oct 1, 10:40 AM ET
- Size
- 11.9 KB